Finally, arGLP-1 has been shown to improve the pre- and postprandial lipid profile, with a reduction in the levels of free fatty acids, triglycerides and LDL cholesterol, as well as the fraction of small and dense LDL and a reduction of the increase levels of triglycerides and apo-B48 postprandial.7882 Likewise, it has been reported a reduction in markers of inflammation, plasminogen activator inhibitor type 1 and leptin whereas adiponectin levels increase.47,48 Regarding the adverse effects of this family, the most important are gastrointestinal, especially nausea and vomiting of mild-moderate intensity, which are reduced with time
Im Macie Jepson
Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol)
Diagnostic information was reviewed and verified by an experienced child neurologist (SHM)
Mary's Hospital Sleep Questionnaire , and the Stanford Sleepiness Scale , which are all well-known and empirically validated metrics for measuring sleep quality